As with other chronic disorders that may involve multiple symptoms, a new NRS survey of 1,534 rosacea patients has documented that more than one therapy is often used over the course of managing the condition.

Nearly 80 percent of respondents reported that they had been prescribed more than one medication for their rosacea. Twenty-five percent had been prescribed two medications over the course of treatment, while 22 percent had used three and 29 percent four or more. 

In today’s increasingly complex health care system, it can be important to know the ins and outs of prescription insurance coverage in order to receive the medication that is intended by your doctor.

“With adequate knowledge, rosacea patients are empowered to take proactive measures that may be necessary to receive medical therapy appropriate for their individual cases,” said Dr. John Wolf, chairman of dermatology at Baylor College of Medicine.  “This can be especially important when prior authorizations and ‘step edits’ are required.”

While the ravages of subtype 3 (phymatous) rosacea have been well documented throughout history, today a multitude of options are available to restore a red, swollen or bumpy nose (rhinophyma) to normal appearance.

The knowledgeable use of cosmetics combined with topical medication prescribed by your dermatologist can camouflage the embarrassing redness, bumps and pimples of rosacea with a smooth appearance while medical therapy works to minimize or banish the underlying condition.

A recent patient survey by the National Rosacea Society has documented the importance of compliance with medical therapy, as 88 percent of the respondents said their symptoms reappear or increase in severity if they fail to use their medication as directed.

In the new survey, 74 percent of 658 respondents said they take their rosacea medications as prescribed by their physician. Another 17 percent said they sometimes use their medications as prescribed, and only 9 percent reported they do not follow their doctor's orders.

Although subtype 3 (phymatous) rosacea often involves excess tissue, it can be effectively treated with a range of options appropriate for the severity of the case, according to the standard management options for rosacea recently published by the National Rosacea Society.¹

Soothing cleansing and other measures in addition to medical therapy may help relieve the symptoms of subtype 4 (ocular) rosacea, according to the standard management options for rosacea recently published by the National Rosacea Society (NRS).

"Gentle care in keeping eyelids clean is especially important in keeping eyes with ocular rosacea healthy," said Dr. Marian Macsai, professor of ophthalmology at the University of Chicago and a member of the consensus committee and review panel of 26 medical experts who developed the new standard options.¹

Because the flushing and facial redness of subtype 1 (erythematotelangiectatic) rosacea are difficult to treat with medical therapy, other measures may be especially important for successfully controlling this widespread form of rosacea, according to the standard management options for rosacea recently published by the National Rosacea Society (NRS).¹

Theresa Pignotti jokes that she was born in a dermatologist's office and saw her dermatologist more often than her own father while growing up. Although she had impetigo as a newborn and acne as an adolescent, she was still taken aback by her first rosacea flare-up. In fact, the 54-year-old respiratory therapist from Rhode Island vividly recalls that very day in 2000.

"I thought I would treat myself to a facial for my birthday," Theresa said, "but it just made my face go crazy. I looked like I was sunburned, and I had pimples and pustules all over."

While some signs and symptoms of rosacea can be challenging to control, effective medical therapies have been extensively studied and approved for the treatment of the bumps and pimples of subtype 2 (papulopustular) rosacea, according to the standard management options for rosacea recently published by the National Rosacea Society.¹